research NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.
Search
forResearch
5 / 1000+ resultsresearch Correction to: An evaluation of the federal adverse events reporting system data on adverse effects of 5‑alpha reductase inhibitors
The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.
research Shedding light on the FDA’s 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia
LLLT devices for hair loss need more research to define proper guidelines.
research FDA Reports of Alopecia as an Adverse Event to Isotretinoin
Isotretinoin may cause hair loss, especially in women and young adults.
research Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
Apremilast shows promise for several skin conditions but needs more research.
Community Join
5 / 1000+ resultscommunity Cassiopea Announces FDA Submission of New Drug Application for Clascoterone Cream 1%, the First New Mechanism of Action for Acne in Nearly 40 Years
The conversation is about a new acne treatment cream called Clascoterone Cream 1%, which is the first new mechanism of action for acne in nearly 40 years. One person joked about hoping their face will be as clean as their bald head after using the cream.
community Following the recent IPO and the positive Phase 3 clinical data for VDPHL01 (extended-release oral minoxidil), what is the projected timeline for the FDA submission and the subsequent commercial availability on the market?
Veradermics' extended-release oral minoxidil is expected to be commercially available in 2027-2028, while another company, Minx, may release a similar product sooner. VDPHL01 is considered more clinically validated compared to Minx.
community Recent Study finds Laser caps are more effective than 5% minoxidil for AGA
Laser caps are found to be more effective than 5% minoxidil for treating hair loss, and when combined with minoxidil, they are even more effective. Some users report positive results with laser treatments, while others see no change; the devices are FDA approved, but opinions on their efficacy vary.
community Does DHT Cause Complete Baldness?
Hair cloning technology is advancing, with clinical trials for improved methods expected by 2028 and 2029, potentially offering a solution for hair loss if donor follicles remain. Organtech's expansion into other biotech areas may secure funding, but the effectiveness of cloning depends on the availability of androgen-resistant donor follicles.
community Why us no one talking about this?
A new hair loss treatment reportedly shows a 539% improvement in hair count, but skepticism remains due to unclear placebo results and potential minimal actual hair growth. Many users doubt its effectiveness and market viability, citing high costs and lack of visual proof.
Clinics
6 / 12 results- 23TrichologyPhat'sTyler, TX · US
- 49
Hair SystemsHair Loss TreatmentsL & L Phat Dos Beauty Salon & Hair Restoration Center LLCKilleen, TX · US - 73
Hair TransplantVIDA Skin and Hair Transplant ClinicBengaluru, Karnataka · IN - 55SMPVT EstheticsJohannesburg · ZA
- 47
Hair TransplantVYTA Aesthetics & Hair TransplantPretoria · ZA - 58
Hair TransplantVita Estetic Hair ClinicIstanbul · TR
Experts
6 / 20 results- 70
Hair Transplant SurgeonDr. Fouad Besrour, MD
Frankfurt am Main, Hessen, Germany
- 71
Hair Transplant SurgeonDr. Fatih Tasalan
Istanbul, Türkiye
- 78
Hair Loss SpecialistVidhi Bhavsar
Gandhinagar, Gujarat, India
- 91
Hair Transplant SurgeonDr. Fadi Al-Sabbagh, MD
Doha, Qatar
- 98
Hair Transplant SurgeonDr. Vito C. Quatela, MD
Rochester, NY, United States
- 74
Hair Transplant SurgeonDr. Fuat Guder, MD, FACS
Istanbul, Türkiye
Learn
— no results